MCED

Sunnyvale, California, September 23, 2026 GRAIL, Inc. announced that the U.S. Food and Drug Administration’s Molecular and Clinical Genetics...

Irving, Texas, U.S, September 8, 2026 Caris Life Sciences, an artificial intelligence and precision medicine company, has launched a...

MENLO PARK, Calif., July 16, 2026 GRAIL, Inc. has announced a strategic collaboration with Priority Health, making the Galleri®...

CHICAGO, Illinois, May 31, 2026 Johnson & Johnson has reported pivotal results from the Phase 1b/2 OrigAMI-4 study, demonstrating...

MENLO PARK, California, May 31, 2026 GRAIL, Inc. has unveiled compelling new results from its registrational PATHFINDER 2 study,...

ABBOTT PARK, Ill., April 17, 2026 Abbott has unveiled new data at the AACR Annual Meeting 2026 demonstrating significant...